JP MORGAN/PUT/PFIZER INC/28/0.1/21.03.25 Share Price

Warrant

DE000JL8ZBW7

Market Closed - Börse Stuttgart 02:18:00 05/07/2024 pm IST
0.23 EUR 0.00% Intraday chart for JP MORGAN/PUT/PFIZER INC/28/0.1/21.03.25
Current month-4.17%
1 month+35.29%
Date Price Change
05/24/05 0.23 0.00%
04/24/04 0.23 0.00%
03/24/03 0.23 +4.55%
02/24/02 0.22 -4.35%
01/24/01 0.23 -4.17%

Delayed Quote Börse Stuttgart

Last update July 05, 2024 at 02:18 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying PFIZER, INC.
Issuer J.P. Morgan
WKN JL8ZBW
ISINDE000JL8ZBW7
Date issued 31/07/2023
Strike 28 $
Maturity 21/03/2025 (258 Days)
Parity 10 : 1
Emission price 0.13
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.44
Lowest since issue 0.15
Delta-0.45x
Omega 5.142
Premium8.87x
Gearing11.5x
Moneyness 0.9982
Difference Strike -0.05 $
Difference Strike %-0.18%
Spread 0.01
Spread %4.35%
Theoretical value 0.2250
Implied Volatility 26.21 %
Total Loss Probability 44.82 %
Intrinsic value 0.000000
Present value 0.2250
Break even 25.56 €
Theta-0x
Vega0.01x
Rho-0.01x

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
28.05 USD
Average target price
31.92 USD
Spread / Average Target
+13.78%
Consensus